This retrospective review of NSCLC genomics data from the BC Cancer Genomic Lab Oncopanel Dataset summarizes the frequency of actionable driver mutations (EGFR, KRAS G12C, MET Exon 14 skip, ALK fusion, and ROS1 fusion), PDL-1 expression, and treatment wait times among five health authorities. This evidence concerns the gene ROS1 and breast cancer.